======= NRIP1 ======= == Gene Information == * **Official Symbol**: NRIP1 * **Official Name**: nuclear receptor interacting protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8204|8204]] * **UniProt**: [[https://www.uniprot.org/uniprot/P48552|P48552]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NRIP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NRIP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602490|Open OMIM]] == Function Summary == * **Entrez Summary**: Nuclear receptor interacting protein 1 (NRIP1) is a nuclear protein that specifically interacts with the hormone-dependent activation domain AF2 of nuclear receptors. Also known as RIP140, this protein modulates transcriptional activity of the estrogen receptor. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors. Positive regulator of the circadian clock gene expression: stimulates transcription of ARNTL/BMAL1, CLOCK and CRY1 by acting as a coactivator for RORA and RORC. {ECO:0000269|PubMed:10364267, ECO:0000269|PubMed:11509661, ECO:0000269|PubMed:11518808, ECO:0000269|PubMed:12554755, ECO:0000269|PubMed:15060175, ECO:0000269|PubMed:21628546, ECO:0000269|PubMed:7641693}. No Pfam Domain information is available for this gene. |ovarian follicle rupture| |ovulation from ovarian follicle| |glucocorticoid receptor binding| |retinoid X receptor binding| |ovulation| |nuclear hormone receptor binding| |lipid storage| |cellular response to estradiol stimulus| |androgen receptor signaling pathway| |histone deacetylase complex| |ovulation cycle process| |estrogen receptor binding| |androgen receptor binding| |circadian regulation of gene expression| |ovulation cycle| |intracellular steroid hormone receptor signaling pathway| |female gonad development| |development of primary female sexual characteristics| |female sex differentiation| |histone deacetylase binding| |steroid hormone mediated signaling pathway| |female gamete generation| |response to estradiol| |circadian rhythm| |intracellular receptor signaling pathway| |maintenance of location| |hormone-mediated signaling pathway| |cellular response to steroid hormone stimulus| |gonad development| |development of primary sexual characteristics| |nuclear chromatin| |transcription corepressor activity| |sex differentiation| |rhythmic process| |transcription coactivator activity| |lipid localization| |response to steroid hormone| |nuclear speck| |reproductive structure development| |reproductive system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |developmental process involved in reproduction| |gamete generation| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |response to lipid| |nucleolus| |negative regulation of transcription by RNA polymerase II| |response to hormone| |response to organic cyclic compound| |multi-organism reproductive process| |cellular response to oxygen-containing compound| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|-1.7| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|2.11| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15914 * **Expression level (log2 read counts)**: 6.06 {{:chemogenomics:nalm6 dist.png?nolink |}}